Target intelligence / Profile preview

Glutathione (GSH) (GSH)

Target
GSH
Molecular classification
Antioxidant, Tripeptide, Redox buffer, Metabolic intermediate
01

Overview

Glutathione is a vital tripeptide consisting of glutamate, cysteine, and glycine, serving as the most abundant low-molecular-weight thiol and primary endogenous antioxidant in mammalian cells (PubChem, CID 124886). It plays a fundamental role in maintaining cellular redox homeostasis by scavenging reactive oxygen species and acting as a cofactor for enzymes like glutathione peroxidase (NIH, StatPearls). Beyond its antioxidant capacity, glutathione is essential for the detoxification of xenobiotics and metabolic byproducts through conjugation reactions catalyzed by glutathione S-transferases (PubMed, PMID 24513447). In clinical contexts, glutathione levels are often dysregulated; for instance, depletion is associated with neurodegenerative conditions like Parkinson's disease and chronic liver injury, whereas elevated levels in malignant cells can confer resistance to chemotherapy and radiation (PubMed, PMID 11396606). Therapeutic interventions target this system either by replenishing the pool with precursors like N-acetylcysteine to treat toxicity or by depleting it to sensitize cancer cells to oxidative damage (PubMed, PMID 28263961).

Other names
L-gamma-glutamyl-L-cysteinyl-glycineReduced glutathioneEndogenous glutathione poolCellular redox system
02

Mechanism of action

Drugs modulate the glutathione pool by providing biosynthetic precursors (e.g., N-acetylcysteine), inhibiting rate-limiting enzymes like glutamate-cysteine ligase (e.g., buthionine sulfoximine), or inducing glutathione depletion through conjugation and export (e.g., acetaminophen or erastin-mediated ferroptosis induction).

03

Biological functions

Redox homeostasisAntioxidant defenseDetoxificationApoptosis regulationSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseLiver diseaseInflammationCardiovascular disease
05

Safety considerations

Hepatotoxicity upon depletionPotential interference with ROS-dependent chemotherapiesOxidative stress-induced cell deathHypersensitivity reactions to precursors
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

GSH/GSSG ratioGlutathione S-transferase (GST) activityCysteine levelsMalondialdehyde (MDA)

Beyond the preview

Go deeper on Glutathione (GSH) (GSH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione (GSH) (GSH).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call